The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 66 , ISSUE 4 ( October-December, 2024 ) > List of Articles

CASE REPORT

Diffuse Large B-cell Lymphoma Presenting as Empyema: A Case Report and Review of Literature

Rasheeka VP, Swadha Jain, Satyam Agarwal, Pradeep Bajad, Sourabh Pahuja, Arjun Khanna

Keywords : Case report, Diffuse large B-cell lymphoma, Empyema, Lymphoma, Pleural effusion

Citation Information : VP R, Jain S, Agarwal S, Bajad P, Pahuja S, Khanna A. Diffuse Large B-cell Lymphoma Presenting as Empyema: A Case Report and Review of Literature. Indian J Chest Dis Allied Sci 2024; 66 (4):140-142.

DOI: 10.5005/jp-journals-11007-0128

License: CC BY-NC 4.0

Published Online: 13-02-2025

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aim and background: Non-Hodgkin lymphoma (NHL) is the most common hematological malignancy, and diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype. It is a highly aggressive B-cell lymphoma resulting in the clonal proliferation of a germinal or post-germinal malignant B cell. The diagnosis is confirmed by biopsy of the affected node/extra-nodal site. Pleural involvement in lymphoma has a diverse presentation; however, presentation as an empyema, as in our case, has not been reported previously. Case description: We present a very rare case of a young, previously healthy female patient who presented with a right-sided pleural collection, who was initially suspected to have empyema due to characteristic findings on ultrasonography and pleural fluid appearance. Her pleural fluid cytology revealed atypical cells and was later diagnosed with an underlying anterior mediastinal mass confirmed to be DLBCL. Conclusion: Empyema may be the first harbinger of malignancy, especially in young immunocompetent patients. Timely diagnosis may be challenging but it improves the prognosis of such patients. Clinical significance: In a TB-endemic country like India, a patient with empyema poses a diagnostic dilemma. Cytology/biopsy and immunohistochemistry aid in diagnosis in such cases. Imaging also plays a key role in tumor staging, therapeutic planning, and follow-up of patients.


PDF Share
  1. Angirish B, Sanghavi P, Jankharia B. Pulmonary manifestations of lymphoma: A pictorial essay. Lung India 2020;37(3):263–267. DOI: 10.4103/lungindia.lungindia_200_19.
  2. Bligh MP, Borgaonkar JN, Burrell SC, et al. Spectrum of CT findings in thoracic extranodal non-Hodgkin lymphoma. Radiographics 2017;37(2):439–461. DOI: 10.1148/rg.2017160077.
  3. Porcel JM, Cuadrat I, García-Cerecedo T, et al. Pleural effusions in diffuse large B-cell lymphoma: Clinical and prognostic significance. Lung 2019;197(1):47–51. DOI: 10.1007/s00408-018-0182-y.
  4. Chen YP, Huang HY, Lin KP, et al. Malignant effusions correlate with poorer prognosis in patients with diffuse large B-cell lymphoma. Am J Clin Pathol 2015;143(5):707–715. DOI: 10.1309/AJCP6LXA2LK FZAMC.
  5. Ito T, Fujita K, Okamura M, et al. Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma. Respir Med Case Rep 2020;31:101206. DOI: 10.1016/j.rmcr.2020.10 1206.
  6. Chang YC, Liu KT, Lin YG, et al. A rare primary pericardial DLBCL masquerading as an unexplained malignant pleural effusion in an elderly woman: A case report. Ann Med Surg (Lond) 2022;82:104516. DOI: 10.1016/j.amsu.2022.104516.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.